These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 21866962)

  • 1. Novel peptide-specific quantitative structure-activity relationship (QSAR) analysis applied to collagen IV peptides with antiangiogenic activity.
    Rivera CG; Rosca EV; Pandey NB; Koskimaki JE; Bader JS; Popel AS
    J Med Chem; 2011 Oct; 54(19):6492-500. PubMed ID: 21866962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergy between a collagen IV mimetic peptide and a somatotropin-domain derived peptide as angiogenesis and lymphangiogenesis inhibitors.
    Koskimaki JE; Lee E; Chen W; Rivera CG; Rosca EV; Pandey NB; Popel AS
    Angiogenesis; 2013 Jan; 16(1):159-70. PubMed ID: 23053781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.
    Zhang GM; Zhang YM; Fu SB; Liu XH; Fu X; Yu Y; Zhang ZY
    Chin Med J (Engl); 2008 Nov; 121(22):2324-30. PubMed ID: 19080341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a biomimetic peptide derived from collagen IV with anti-angiogenic activity in breast cancer.
    Rosca EV; Koskimaki JE; Pandey NB; Wolff AC; Popel AS
    Cancer Biol Ther; 2011 Nov; 12(9):808-17. PubMed ID: 21878750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of breast cancer growth and metastasis by a biomimetic peptide.
    Lee E; Lee SJ; Koskimaki JE; Han Z; Pandey NB; Popel AS
    Sci Rep; 2014 Nov; 4():7139. PubMed ID: 25409905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Collagen IV and CXC chemokine-derived antiangiogenic peptides suppress glioma xenograft growth.
    Rosca EV; Lal B; Koskimaki JE; Popel AS; Laterra J
    Anticancer Drugs; 2012 Aug; 23(7):706-12. PubMed ID: 22495619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small peptides derived from somatotropin domain-containing proteins inhibit blood and lymphatic endothelial cell proliferation, migration, adhesion and tube formation.
    Lee E; Rosca EV; Pandey NB; Popel AS
    Int J Biochem Cell Biol; 2011 Dec; 43(12):1812-21. PubMed ID: 21920451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of potent and practical antiangiogenic agents inspired by cortistatin A.
    Czakó B; Kürti L; Mammoto A; Ingber DE; Corey EJ
    J Am Chem Soc; 2009 Jul; 131(25):9014-9. PubMed ID: 19469509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pentastatin-1, a collagen IV derived 20-mer peptide, suppresses tumor growth in a small cell lung cancer xenograft model.
    Koskimaki JE; Karagiannis ED; Tang BC; Hammers H; Watkins DN; Pili R; Popel AS
    BMC Cancer; 2010 Feb; 10():29. PubMed ID: 20122172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The novel model peptide, αAL14, regulates angiogenesis by inhibiting VEGFR 2-mediated signaling in HUVECs.
    Kim NH; Kang CW; Go HJ; Kim CH; Park NG; Kim GD
    Int J Oncol; 2016 Oct; 49(4):1457-68. PubMed ID: 27511296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-angiogenic quassinoid-rich fraction from Eurycoma longifolia modulates endothelial cell function.
    Al-Salahi OS; Kit-Lam C; Majid AM; Al-Suede FS; Mohammed Saghir SA; Abdullah WZ; Ahamed MB; Yusoff NM
    Microvasc Res; 2013 Nov; 90():30-9. PubMed ID: 23899415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lamstatin--a novel inhibitor of lymphangiogenesis derived from collagen IV.
    Weckmann M; Moir LM; Heckman CA; Black JL; Oliver BG; Burgess JK
    J Cell Mol Med; 2012 Dec; 16(12):3062-73. PubMed ID: 22998238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and antiangiogenic activity study of new hop chalcone Xanthohumol analogues.
    Nuti E; Bassani B; Camodeca C; Rosalia L; Cantelmo A; Gallo C; Baci D; Bruno A; Orlandini E; Nencetti S; Noonan DM; Albini A; Rossello A
    Eur J Med Chem; 2017 Sep; 138():890-899. PubMed ID: 28750311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Novel Peptide Derived From Tissue-Type Plasminogen Activator Potently Inhibits Angiogenesis and Corneal Neovascularization.
    Kim HK; Choi JS; Lee SW; Joo CK; Joe YA
    J Cell Biochem; 2017 May; 118(5):1132-1143. PubMed ID: 27618679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rational design, structure, and biological evaluation of cyclic peptides mimicking the vascular endothelial growth factor.
    Goncalves V; Gautier B; Coric P; Bouaziz S; Lenoir C; Garbay C; Vidal M; Inguimbert N
    J Med Chem; 2007 Oct; 50(21):5135-46. PubMed ID: 17900101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human endostatin-derived synthetic peptides possess potent antiangiogenic properties in vitro and in vivo.
    Cattaneo MG; Pola S; Francescato P; Chillemi F; Vicentini LM
    Exp Cell Res; 2003 Feb; 283(2):230-6. PubMed ID: 12581742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncothanin, a peptide from the alpha3 chain of type IV collagen, modifies endothelial cell function and inhibits angiogenesis.
    Shahan T; Grant D; Tootell M; Ziaie Z; Ohno N; Mousa S; Mohamad S; Delisser H; Kefalides N
    Connect Tissue Res; 2004; 45(3):151-63. PubMed ID: 15512769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of a designed vascular endothelial growth factor receptor antagonist helical peptide with antiangiogenic activity in vivo.
    Basile A; Del Gatto A; Diana D; Di Stasi R; Falco A; Festa M; Rosati A; Barbieri A; Franco R; Arra C; Pedone C; Fattorusso R; Turco MC; D'Andrea LD
    J Med Chem; 2011 Mar; 54(5):1391-400. PubMed ID: 21280635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-activity relationships of the human prothrombin kringle-2 peptide derivative NSA9: anti-proliferative activity and cellular internalization.
    Hwang HS; Kim DW; Kim SS
    Biochem J; 2006 Apr; 395(1):165-72. PubMed ID: 16390327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on the structure-activity relationship of endostatin: synthesis of human endostatin peptides exhibiting potent antiangiogenic activities.
    Chillemi F; Francescato P; Ragg E; Cattaneo MG; Pola S; Vicentini L
    J Med Chem; 2003 Sep; 46(19):4165-72. PubMed ID: 12954068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.